Downregulation of Plk1 by small molecular inhibitors or siRNA significantly reduces cell invasion and migration in multiple types of cancer cells (Song et al., 2018; Fu and Wen, 2017; Zhou et al., 2020). Here, PLK1 is linked to cancer.